Author: wellspharmatx

There are many 503B outsourcers in the market. According to the FDA’s website, there are currently 70 registered 503B’s.  Many of these have very specific “niches” that they serve, many are CMO’s, and many are private-system outsourcers.  In the market that Wells Pharma is designed to serve, – acute care…

As a new company in a mature market (outsourced sterile drug preparations), Wells Pharma recognizes that we can’t just be “good”…we must be GREAT.  Our competition has name recognition, GPO agreements, large sales teams, and extensive marketing budgets.  However, one of the weaknesses of being big is that customer service…

This leadership team understands the 503B market is laden with pitfalls and dangers. Because of that, QUALITY is the most important thing we can offer our customers and patients. So, how does Wells Pharma maintain the highest quality standards? In addition to producing products in a sterile environment and using…

As the Vice President of Sales for Wells Pharma, it is my responsibility to lead a brand-new company into the competitive market of 503B sterile outsourced drugs.  We provide Ready-To-Use medications to hospitals and surgery centers, saving them time, reducing their cost, extending the shelf-life of their drugs, and increasing…